Drug-induced cholestasis.
Drug-induced cholestasis is a common entity, seen with numerous classes of pharmacological agents. A high index of suspicion is required for the correct diagnosis. Different clinical syndromes may be recognized, with variable degrees of hepatitis in association with cholestasis. The most important aspect of treatment is prompt discontinuation of the offending drug. Several agents have been used for symptomatic relieve of the pruritus associated with cholestasis, including cholestyramine, ursodeoxycholic acid, and opiate antagonists, with limited results. Prognosis is usually good, with few cases of prolonged cholestasis leading to vanishing bile duct syndrome. Liver failure may rarely occur if diagnosis goes unrecognized and the inciting drug is not withdrawn.
Levy
Cynthia
C
Division of Gastroenterology and Hepatology, W 19A, Mayo Clinic and Foundation, 200 1st Street, SW, Rochester, MN 55905, USA.
Lindor
Keith D
KD
D000818:Animals; D000900:Anti-Bacterial Agents / Q000009:adverse effects; D000894:Anti-Inflammatory Agents, Non-Steroidal / Q000009:adverse effects; D001649:Bile Duct Diseases / Q000139:chemically induced / Q000473:pathology / Q000628:therapy; D002779:Cholestasis / Q000139:chemically induced* / Q000473:pathology / Q000628:therapy; D003271:Contraceptive Agents, Female / Q000009:adverse effects; D006801:Humans; D007004:Hypoglycemic Agents / Q000009:adverse effects; D007166:Immunosuppressive Agents / Q000009:adverse effects; D028321:Plant Preparations / Q000009:adverse effects; D011537:Pruritus / Q000139:chemically induced / Q000473:pathology / Q000628:therapy
D000900:Anti-Bacterial Agents; D000894:Anti-Inflammatory Agents, Non-Steroidal; D003271:Contraceptive Agents, Female; D007004:Hypoglycemic Agents; D007166:Immunosuppressive Agents; D028321:Plant Preparations